NOVEL ULTRASENSITIVE CANCER BIOMARKER ASSAY PLATFORM UTILIZING PALLADIUM CATALYZED HIGH-GAIN CHEMICAL AMPLIFICATION


Year of Award:
2015
Award Type:
R43
Project Number:
CA192674
RFA Number:
PAR-13-327
Technology Track:
Molecular & Cellular Analysis Technologies
PI/Project Leader:
LELENTAL, MARK
Other PI or Project Leader:
N/A
Institution:
CATASSAYS
We propose to use CatAssays' novel Palladium Catalyzed Chemical Amplification (PdCCA) technology platform to develop ultra-sensitive sandwich ELISA-format bioassays to detect very low concentrations of a number of critical cancer and immunoregulatory biom